Profile of the triplex assay for detection of chlamydia, gonorrhea and trichomonas using the BD MAX™ System

References

• World Health Organization. Global incidence and prevalence of selected curable sexually transmitted infections - 2008. Geneva: WHO Press; 2012.
   Google Scholar
• Newman L, Rowley J, Vander Hoorn S, et al. Global estimates of the prevalence and incidence of four curable sexually transmitted infections in 2012 based on systematic review and global reporting. PLoS One. 2015;10(12):e0143304.
   PubMed Web of Science ®Google Scholar
• Price MJ, Ades AE, De Angelis D, et al. Risk of pelvic inflammatory disease following Chlamydia trachomatis infection: analysis of prospective studies with a multistate model. Am J Epidemiol. 2013;178(3):484–492.
   PubMed Web of Science ®Google Scholar
• Gottlieb SL, Xu F, Brunham RC. Screening and treating Chlamydia trachomatis genital infection to prevent pelvic inflammatory disease: interpretation of findings from randomized controlled trials. Sex Transm Dis. 2013;40(2):97–102.
   PubMed Web of Science ®Google Scholar
• Cherpes TL, Wiesenfeld HC, Melan MA, et al. The associations between pelvic inflammatory disease, Trichomonas vaginalis infection, and positive herpes simplex virus type 2 serology. Sex Transm Dis. 2006;33(12):747–752.
   PubMed Web of Science ®Google Scholar
• Moodley P, Wilkinson D, Connolly C, et al. Trichomonas vaginalis is associated with pelvic inflammatory disease in women infected with Human Immunodeficiency Virus. Clin Infect Dis. 2002;34(4):519–522.
   PubMed Web of Science ®Google Scholar
• Herzog SA, Heijne JC, Althaus CL, et al. Describing the progression from Chlamydia trachomatis and Neisseria gonorrhoeae to pelvic inflammatory disease: systematic review of mathematical modeling studies. Sex Transm Dis. 2012;39(8):628–637.
   PubMed Web of Science ®Google Scholar
• Rekart ML, Gilbert M, Meza R, et al. Chlamydia public health programs and the epidemiology of pelvic inflammatory disease and ectopic pregnancy. J Infect Dis. 2013;207(1):30–38.
   PubMed Web of Science ®Google Scholar
• Romoren M, Velauthapillai M, Rahman M, et al. Trichomoniasis and bacterial vaginosis in pregnancy: inadequately managed with the syndromic approach. Bull World Health Organ. 2007;85:297–304.
   PubMed Web of Science ®Google Scholar
• Silver BJ, Guy RJ, Kaldor JM, et al. Trichomonas vaginalis as a cause of perinatal morbidity: a systematic review and meta-analysis. Sex Transm Dis. 2014;41(6):369–376.
   PubMed Web of Science ®Google Scholar
• Mavedzenge SN, Van Der Pol B, Cheng H, et al. Epidemiological synergy of Trichomonas vaginalis and HIV in Zimbabwean and South African women. Sex Transm Dis. 2010;37(7):460–466.
   PubMed Web of Science ®Google Scholar
• Kissinger P, Adamski A. Trichomoniasis and HIV interactions: a review. Sex Transm Infect. 2013;89(6):426–433.
   PubMed Web of Science ®Google Scholar
• Sexton J, Garnett G, Rottingen JA. Metaanalysis and metaregression in interpreting study variability in the impact of sexually transmitted diseases on susceptibility to HIV infection. Sex Transm Dis. 2005;32(6):351–357.
   PubMed Web of Science ®Google Scholar
• Workowski KA. Centers for Disease Control and Prevention Sexually Transmitted Diseases Treatment Guidelines. Clin Infect Dis. 2015;61 Suppl 8(suppl8):S759–762.
   PubMed Web of Science ®Google Scholar
• Unemo M, Shafer WM. Antimicrobial resistance in Neisseria gonorrhoeae in the 21st century: past, evolution, and future. Clin Microbiol Rev. 2014;27(3):587–613.
   PubMed Web of Science ®Google Scholar
• Ginocchio CC, Chapin K, Smith JS, et al. Prevalence of Trichomonas vaginalis and coinfection with Chlamydia trachomatis and Neisseria gonorrhoeae in the United States as determined by the Aptima Trichomonas vaginalis nucleic acid amplification assay. J Clin Microbiol. 2012;50(8):2601–2608.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Kwok C, Pierre-Louis B, et al. Trichomonas vaginalis infection and human immunodeficiency virus acquisition in African women. J Infect Dis. 2008;197(4):548–554.
   PubMed Web of Science ®Google Scholar
• Lazenby GB, Unal ER, Andrews AL, et al. Cost-effectiveness analysis of annual Trichomonas vaginalis screening and treatment in HIV-positive women to prevent HIV transmission. Sex Transm Dis. 2014;41(6):353–358.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention. Sexually transmitted disease surveillance 2015. Atlanta: US Department of Health & Human Services; 2016.
   Google Scholar
• Bender N, Herrmann B, Andersen B, et al. Chlamydia infection, pelvic inflammatory disease, ectopic pregnancy and infertility: cross-national study. Sex Transm Infect. 2011;87(7):601–608.
   PubMed Web of Science ®Google Scholar
• Papp J, Schachter J, Gaydos C, et al. Recommendations for the laboratory-based detection of Chlamydia trachomatis and Neisseria gonorrhoeae — 2014. MMWR. 2014;63(RR–2):1–24.
   PubMed Web of Science ®Google Scholar
• Nathan B, Appiah J, Saunders P, et al. Microscopy outperformed in a comparison of five methods for detecting Trichomonas vaginalis in symptomatic women. Int J STD AIDS. 2015;26(4):251–256.
   PubMed Web of Science ®Google Scholar
• Kissinger P. Epidemiology and treatment of trichomoniasis. Curr Infect Dis Rep. 2015;17(6):1–9.
   Web of Science ®Google Scholar
• Muzny CA, Blackburn RJ, Sinsky RJ, et al. Added benefit of nucleic acid amplification testing for the diagnosis of Trichomonas vaginalis among men and women attending a sexually transmitted diseases clinic. Clin Infect Dis. 2014;59(6):834–841.
   PubMed Web of Science ®Google Scholar
• Hobbs MM, Sena AC. Modern diagnosis of Trichomonas vaginalis infection. Sex Transm Infect. 2013;89:434–438.
   PubMed Web of Science ®Google Scholar
• Dalpke AH, Hofko M, Stock C, et al. Evaluation of the BD Max MRSA XT assay for use with different swab types. J Clin Microbiol. 2014;52(12):4343–4346.
   PubMed Web of Science ®Google Scholar
• Mendes RE, Watters AA, Rhomberg PR, et al. Performance of BD Max StaphSR for screening of methicillin-resistant Staphylococcus aureus Isolates among a contemporary and diverse collection from 146 institutions located in nine U.S. Census regions: prevalence of mecA dropout mutants. J Clin Microbiol. 2016;54(1):204–207.
   PubMed Web of Science ®Google Scholar
• Stellrecht KA, Espino AA, Maceira VP, et al. Premarket evaluations of the IMDx C. difficile for Abbott m2000 assay and the BD Max Cdiff assay. J Clin Microbiol. 2014;52(5):1423–1428.
   PubMed Web of Science ®Google Scholar
• Dalpke AH, Hofko M, Zorn M, et al. Evaluation of the fully automated BD MAX Cdiff and Xpert C. difficile assays for direct detection of Clostridium difficile in stool specimens. J Clin Microbiol. 2013;51(6):1906–1908.
   PubMed Web of Science ®Google Scholar
• Anderson NW, Buchan BW, Ledeboer NA. Comparison of the BD MAX Enteric Bacterial Panel to routine culture methods for detection of Campylobacter, Enterohemorrhagic Escherichia coli (O157), Salmonella, and Shigella isolates in preserved stool specimens. J Clin Microbiol. 2014;52(4):1222–1224.
   PubMed Web of Science ®Google Scholar
• Mölling P, Nilsson P, Ennefors T, et al. Evaluation of the BD Max Enteric Parasite Panel for clinical diagnostics. J Clin Microbiol. 2016;54(2):443–444.
   PubMed Web of Science ®Google Scholar
• Silbert S, Rocchetti TT, Gostnell A, et al. Detection of Group B Streptococcus directly from collected E-swab samples by use of the BD Max GBS Assay. J Clin Microbiol. 2016;54(6):1660–1663.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Williams JA, Fuller D, et al. Chlamydia, Gonorrhea and Trichomonas combined testing using the BD MAX™ CT/GC/TV assay using genitourinary specimen types. J Clin Microbiol. 2017;55(1):155–164.
   PubMed Web of Science ®Google Scholar
• Golparian D, Boräng S, Sundqvist M, et al. Evaluation of the new BD Max GC real-time PCR assay, analytically and clinically as a supplementary test for the BD ProbeTec GC Qx amplified DNA assay, for molecular detection of Neisseria gonorrhoeae. J Clin Microbiol. 2015;53(12):3935–3937.
   PubMed Web of Science ®Google Scholar
• Antonelli A, Arena F, Giani T, et al. Performance of the BD MAX™ instrument with check-direct CPE real-time PCR for the detection of carbapenemase genes from rectal swabs, in a setting with endemic dissemination of carbapenemase-producing Enterobacteriaceae. Diagn Microbiol Infect Dis. 2016;86(1):30–34.
   PubMed Web of Science ®Google Scholar
• Dalpke AH, Hofko M, Zimmermann S. Development of a real-time PCR protocol requiring minimal handling for detection of vancomycin-resistant Enterococci with the fully automated BD Max System. J Clin Microbiol. 2016;54(9):2321–2329.
   PubMed Web of Science ®Google Scholar
• Kenicer J, Hardie A, Hamilton F, et al. Comparative evaluation of the Diagenode multiplex PCR assay on the BD Max System versus a routine in-house assay for detection of Bordetella pertussis. J Clin Microbiol. 2014;52(7):2668–2670.
   PubMed Web of Science ®Google Scholar
• Cárdenas AM, Edelstein PH, Alby K. Development and optimization of a real-time PCR assay for detection of Herpes Simplex and Varicella-Zoster viruses in skin and mucosal lesions by use of the BD Max Open System. J Clin Microbiol. 2014;52(12):4375–4376.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Hook EW 3rd, Williams JA, et al. Performance of the BD CTQx and GCQx amplified assays on the BD Viper LT compared with the BD Viper XTR System. Sex Transm Dis. 2015;42(9):521–523.
   PubMed Web of Science ®Google Scholar
• Chernesky M, Jang D, Gilchrist J, et al. Head to head comparison of second generation nucleic acid amplification tests for Chlamydia trachomatis and Neisseria gonorrhoeae on female urines and self-collected vaginal swabs. J Clin Microbiol. 2014;52:2305–2310.
   PubMed Web of Science ®Google Scholar
• Van Der Pol B, Williams JA, Taylor SN, et al. Detection of Trichomonas vaginalis DNA by use of self-obtained vaginal swabs with the BD ProbeTec Qx assay on the BD Viper system. J Clin Microbiol. 2014;52(3):885–889.
   PubMed Web of Science ®Google Scholar
• Ratnam S, Jang D, Gilchrist J, et al. Workflow and maintenance characteristics of five automated laboratory instruments for the diagnosis of sexually transmitted infections. J Clin Microbiol. 2014;52(7):2299–2304.
   PubMed Web of Science ®Google Scholar
• Williams JA, Eddleman L, Pantone A, et al. Time-motion analysis of four automated systems for the detection of Chlamydia trachomatis and Neisseria gonorrhoeae by nucleic acid amplification testing. J Lab Autom. 2014;19(4):423–426.
   PubMedGoogle Scholar
• Harindra V, Tobin JM, Underhill G. Opportunistic chlamydia screening; should positive patients be screened for co-infections? Int J STD AIDS. 2002;13(12):821–825.
   PubMed Web of Science ®Google Scholar
• Getman D. Prevalence of M. genitalium, T. vaginalis, C. trachomatis and N. gonorrhoeae in women enrolled in a prospective multi-center US clinical study. 2014 National STD Prevention Conference. Atlanta, GA. June; Sex Transm Dis. 2014;41(S1).
   Google Scholar
• Op De Coul ELM, Warning TD, Koedijk FDH. Sexual behaviour and sexually transmitted infections in sexually transmitted infection clinic attendees in the Netherlands, 2007–2011. Int J STD AIDS. 2014;25(1):40–51.
   PubMed Web of Science ®Google Scholar